NLGN3, neuroligin 3, 54413

N. diseases: 63; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013170
Disease: Drug habituation
Drug habituation
0.010 Biomarker phenotype BEFREE We clustered genes by similarity in phenomic profiles and used epistasis analysis to discover parallel networks centered on <i>CHD8•chd-7</i> and <i>NLGN3•nlg-1</i> that underlie mechanosensory hyperresponsivity and impaired habituation learning. 31754030 2020
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 AlteredExpression disease BEFREE In summary, we found NLGN3 promoted neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway and providing a new target for neuroblastoma therapy. 31150649 2019
CUI: C0426317
Disease: Genitourinary symptoms
Genitourinary symptoms
0.010 GeneticVariation phenotype BEFREE We report gut symptoms in patients with the autism-associated R451C mutation encoding the neuroligin-3 protein. 31119867 2019
CUI: C0679407
Disease: Gastrointestinal dysfunction
Gastrointestinal dysfunction
0.010 GeneticVariation phenotype BEFREE Gastrointestinal dysfunction in patients and mice expressing the autism-associated R451C mutation in neuroligin-3. 31119867 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.010 AlteredExpression disease BEFREE In summary, we found NLGN3 promoted neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway and providing a new target for neuroblastoma therapy. 31150649 2019
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.010 Biomarker group BEFREE Our report of two missense variants affecting the normal localization of NLGN3 in a total of five affected individuals reinforces the involvement of the NLGN3 gene in a neurodevelopmental disorder characterized by ID and ASD. 31184401 2019
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.010 AlteredExpression disease BEFREE In summary, we found NLGN3 promoted neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway and providing a new target for neuroblastoma therapy. 31150649 2019
CUI: C4726566
Disease: Extracranial Solid Neoplasm
Extracranial Solid Neoplasm
0.010 Biomarker disease BEFREE Neuroblastoma is the most common extracranial solid tumor of childhood, previous studies show synaptic protein neuroligin-3 (NLGN3) promotes glioma proliferation and growth, However, no investigation about the role of NLGN3 in neuroblastoma was reported. 31150649 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.010 Biomarker disease BEFREE The role of NLGN3 in regulating depression in mice was confirmed in vitro using astrocytes stimulated by LPS that NLGN3 knockdown reduced LPS-induced inflammation. 29775613 2018
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE The role of NLGN3 in regulating depression in mice was confirmed in vitro using astrocytes stimulated by LPS that NLGN3 knockdown reduced LPS-induced inflammation. 29775613 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE In a series of validation experiments, we tested mice with different pathologies, including neuroligin-3 deficient mice (male Nlgn3<sup>y/-</sup> and female Nlgn3<sup>+/-</sup>) for autistic behavior, oligodendrocyte-specific erythropoietin receptor knockout (oEpoR<sup>-/-</sup>) mice for cognitive impairment, as well as mouse models of renal failure (unilateral ureteral obstruction and 5/6 nephrectomy) and of type 2 diabetes (ApoE<sup>-/-</sup>) - for delineating potentially confounding effects of motivational factors (thirst, glucose-craving) on learning and memory assessments. 29474958 2018
CUI: C0019569
Disease: Hirschsprung Disease
Hirschsprung Disease
0.010 GeneticVariation disease BEFREE Several SNPs were significantly associated with altered risk of HD in the Chinese Han population, including rs1421589 within <i>NRXN1</i>, rs11795613 and rs4844285 within <i>NLGN3,</i> as well as rs5961397, rs7157669 and rs724373 within <i>NLGX4X</i> (all P<0.05). 29622757 2018
CUI: C0035078
Disease: Kidney Failure
Kidney Failure
0.010 Biomarker disease BEFREE In a series of validation experiments, we tested mice with different pathologies, including neuroligin-3 deficient mice (male Nlgn3<sup>y/-</sup> and female Nlgn3<sup>+/-</sup>) for autistic behavior, oligodendrocyte-specific erythropoietin receptor knockout (oEpoR<sup>-/-</sup>) mice for cognitive impairment, as well as mouse models of renal failure (unilateral ureteral obstruction and 5/6 nephrectomy) and of type 2 diabetes (ApoE<sup>-/-</sup>) - for delineating potentially confounding effects of motivational factors (thirst, glucose-craving) on learning and memory assessments. 29474958 2018
CUI: C0041956
Disease: Ureteral obstruction
Ureteral obstruction
0.010 Biomarker phenotype BEFREE In a series of validation experiments, we tested mice with different pathologies, including neuroligin-3 deficient mice (male Nlgn3<sup>y/-</sup> and female Nlgn3<sup>+/-</sup>) for autistic behavior, oligodendrocyte-specific erythropoietin receptor knockout (oEpoR<sup>-/-</sup>) mice for cognitive impairment, as well as mouse models of renal failure (unilateral ureteral obstruction and 5/6 nephrectomy) and of type 2 diabetes (ApoE<sup>-/-</sup>) - for delineating potentially confounding effects of motivational factors (thirst, glucose-craving) on learning and memory assessments. 29474958 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 AlteredExpression disease BEFREE Glioblastoma recurrence correlates with NLGN3 levels. 29777576 2018
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.010 AlteredExpression disease BEFREE Glioblastoma recurrence correlates with NLGN3 levels. 29777576 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.010 Biomarker phenotype BEFREE The role of NLGN3 in regulating depression in mice was confirmed in vitro using astrocytes stimulated by LPS that NLGN3 knockdown reduced LPS-induced inflammation. 29775613 2018
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 AlteredExpression group BEFREE An important mechanism that mediates this neural regulation of brain cancer is activity-dependent cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), which promotes glioma proliferation through the PI3K-mTOR pathway. 28959975 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE ADAM10 inhibitors prevent the release of NLGN3 into the tumour microenvironment and robustly block HGG xenograft growth. 28959975 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 GeneticVariation disease BEFREE In humans, mutations in NLGN3 and NLGN4 are linked to autism and schizophrenia; NLGN2 missense variants are implicated in schizophrenia. 27865048 2017
CUI: C0037317
Disease: Sleep disturbances
Sleep disturbances
0.010 GeneticVariation phenotype BEFREE The sleep disruptions in Nlgn3 KO rats are consistent with observations of sleep disturbances in ASD patients. 28958035 2017
CUI: C0150080
Disease: Social Communication Disorder
Social Communication Disorder
0.010 GeneticVariation disease BEFREE The Neuroligin-3 (NL3) mouse, expressing a R451C mutation discovered in two Swedish brothers with ASD, exhibits impaired social interactions and heightened aggressive behavior towards male mice. 28255463 2017
CUI: C0153633
Disease: Malignant neoplasm of brain
Malignant neoplasm of brain
0.010 AlteredExpression disease BEFREE An important mechanism that mediates this neural regulation of brain cancer is activity-dependent cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), which promotes glioma proliferation through the PI3K-mTOR pathway. 28959975 2017
CUI: C0424295
Disease: Hyperactive behavior
Hyperactive behavior
0.010 Biomarker phenotype BEFREE Nlgn3 KO rats were hyperactive, exhibited excessive chewing behavior, and had impaired prepulse inhibition to an auditory startle stimulus. 28958035 2017
CUI: C0555198
Disease: Malignant Glioma
Malignant Glioma
0.010 AlteredExpression disease BEFREE Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. 28959975 2017